Policy Brief 37, March 2017
The Need to Avoid “TRIPS-Plus” Patent Clauses in Trade Agreements
A recent article in a prestigious journal reminds us of how the intellectual property chapter of free trade agreements can prevent the sick from getting treatment. This article also critiques the TPP clauses and warns that they should not be translated to national laws or copied into other FTAs being negotiated.
This article was tagged: Affordable Medicines, Bilateral Investment Treaties (BITs), Compulsory Licenses, Dispute Settlement, Flexibilities, Free Trade Agreements (FTAs), Human Rights, Intellectual Property, Investment Agreement, Patent, TRIPS, WTO
